Advertisement

The N-end rule pathway enzyme Naa10 supports epiblast specification in mouse embryonic stem cells by modulating FGF/MAPK

  • Daisuke Takekoshi
  • Yoshimi Tokuzawa
  • Masahiro Sakanaka
  • Hidemasa KatoEmail author
Article
  • 21 Downloads

Abstract

N-terminal acetylation (Nt-acetylation) refers to the acetylation of the free α-amino group at the N-terminus of a polypeptide. While the effects of Nt-acetylation are multifaceted, its most known function is in the acetylation-dependent N-end rule protein degradation pathway (Ac/N-end rule pathway), where Nt-acetylation is recognized as a degron by designated E3 ligases, eventually leading to target degradation by the ubiquitin-proteasome system. Naa10 is the catalytic subunit of the major Nt-acetylation enzyme NatA, which Nt-acetylates proteins whose second amino acid has a small side chain. In humans, NAA10 is the responsible mutated gene in Ogden syndrome and is thought to play important roles in development. However, it is unclear how the Ac/N-end rule pathway affects the differentiation ability of mouse embryonic stem cells (mESCs). We hypothesized that the balance of pluripotency factors may be maintained by the Ac/N-end rule pathway. Thus, we established Naa10 knockout mESCs to test this hypothesis. We found that Naa10 deficiency attenuated differentiation towards the epiblast lineage, deviating towards primitive endoderm. However, this was not caused by disturbing the balance of pluripotency factors, rather by augmenting FGF/MAPK signaling.

Keywords

Naa10 Ard1 N-end rule FGF/MAPK signal Pluripotency factors 

Notes

Acknowledgments

We thank James P. Mahaffey, PhD, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript. We thank Mr. Naohito Tokunaga at the Division of Analytical Bio-Medicine the Advanced Research Support Center (ADRES), Ehime University for his technical assistance.

Funding

This work was supported by JSPS KAKENHI (grant number JP18J11231).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11626_2019_341_Fig6_ESM.png (194 kb)
Fig. S1

(related to Fig. 3C) qRT-PCR for additional pluripotency and lineage markers in 2iLIF-withdrawal differentiation. (PNG 194 kb)

11626_2019_341_MOESM1_ESM.tif (350 kb)
High resolution image (TIF 350 kb)

References

  1. Aksnes H, Hole K, Arnesen T (2015) Molecular, cellular, and physiological significance of N-terminal acetylation. Int Rev Cell Mol Biol 316:267–305CrossRefGoogle Scholar
  2. Aksoy I, Giudice V, Delahaye E, Wianny F, Aubry M, Mure M, Chen J, Jauch R, Bogu GK, Nolden T, Himmelbauer H, Xavier Doss M, Sachinidis A, Schulz H, Hummel O, Martinelli P, Hubner N, Stanton LW, Real FX, Bourillot PY, Savatier P (2014) Klf4 and Klf5 differentially inhibit mesoderm and endoderm differentiation in embryonic stem cells. Nat Commun 5:3719CrossRefGoogle Scholar
  3. Chambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A (2007) Nanog safeguards pluripotency and mediates germline development. Nature 450:1230–1234CrossRefGoogle Scholar
  4. Chazaud C, Yamanaka Y (2016) Lineage specification in the mouse preimplantation embryo. Development 143:1063–1074CrossRefGoogle Scholar
  5. Chazaud C, Yamanaka Y, Pawson T, Rossant J (2006) Early lineage segregation between epiblast and primitive endoderm in mouse blastocysts through the Grb2-MAPK pathway. Dev Cell 10:615–624CrossRefGoogle Scholar
  6. DeVeale B, Brokhman I, Mohseni P, Babak T, Yoon C, Lin A, Onishi K, Tomilin A, Pevny L, Zandstra PW, Nagy A, van der Kooy D (2013) Oct4 is required ~E7.5 for proliferation in the primitive streak. PLoS Genet 9:e1003957CrossRefGoogle Scholar
  7. Dorfel MJ, Lyon GJ (2015) The biological functions of Naa10 - from amino-terminal acetylation to human disease. Gene 567:103–131CrossRefGoogle Scholar
  8. Frum T, Halbisen MA, Wang C, Amiri H, Robson P, Ralston A (2013) Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. Dev Cell 25:610–622CrossRefGoogle Scholar
  9. Hayashi Y, Furue MK, Okamoto T, Ohnuma K, Myoishi Y, Fukuhara Y, Abe T, Sato JD, Hata R, Asashima M (2007) Integrins regulate mouse embryonic stem cell self-renewal. Stem Cells 25:3005–3015CrossRefGoogle Scholar
  10. Hehlgans S, Haase M, Cordes N (2007) Signalling via integrins: implications for cell survival and anticancer strategies. Biochim Biophys Acta 1775:163–180Google Scholar
  11. Hua KT, Tan CT, Johansson G, Lee JM, Yang PW, Lu HY, Chen CK, Su JL, Chen PB, Wu YL, Chi CC, Kao HJ, Shih HJ, Chen MW, Chien MH, Chen PS, Lee WJ, Cheng TY, Rosenberger G, Chai CY, Yang CJ, Huang MS, Lai TC, Chou TY, Hsiao M, Kuo ML (2011) N-alpha-acetyltransferase 10 protein suppresses cancer cell metastasis by binding PIX proteins and inhibiting Cdc42/Rac1 activity. Cancer Cell 19:218–231CrossRefGoogle Scholar
  12. Huang d W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44–57CrossRefGoogle Scholar
  13. Hunt GC, Singh P, Schwarzbauer JE (2012) Endogenous production of fibronectin is required for self-renewal of cultured mouse embryonic stem cells. Exp Cell Res 318:1820–1831CrossRefGoogle Scholar
  14. Hwang CS, Shemorry A, Varshavsky A (2010) N-terminal acetylation of cellular proteins creates specific degradation signals. Science 327:973–977CrossRefGoogle Scholar
  15. Ivanova N, Dobrin R, Lu R, Kotenko I, Levorse J, DeCoste C, Schafer X, Lun Y, Lemischka IR (2006) Dissecting self-renewal in stem cells with RNA interference. Nature. 442:533–538CrossRefGoogle Scholar
  16. Jang J, Wang Y, Lalli MA, Guzman E, Godshalk SE, Zhou H, Kosik KS (2016) Primary cilium-autophagy-Nrf2 (PAN) Axis activation commits human embryonic stem cells to a neuroectoderm fate. Cell 165:410–420CrossRefGoogle Scholar
  17. Kalkan T, Olova N, Roode M, Mulas C, Lee HJ, Nett I, Marks H, Walker R, Stunnenberg HG, Lilley KS, Nichols J, Reik W, Bertone P, Smith A (2017) Tracking the embryonic stem cell transition from ground state pluripotency. Development 144:1221–1234CrossRefGoogle Scholar
  18. Kalkan T, Smith A (2014) Mapping the route from naive pluripotency to lineage specification. Philos Trans R Soc Lond Ser B Biol Sci 369Google Scholar
  19. Kang M, Piliszek A, Artus J, Hadjantonakis AK (2013) FGF4 is required for lineage restriction and salt-and-pepper distribution of primitive endoderm factors but not their initial expression in the mouse. Development 140:267–279CrossRefGoogle Scholar
  20. Kats I, Khmelinskii A, Kschonsak M, Huber F, Kniess RA, Bartosik A, Knop M (2018) Mapping degradation signals and pathways in a eukaryotic N-terminome. Mol Cell 70:488–501 e485CrossRefGoogle Scholar
  21. Kopp JL, Ormsbee BD, Desler M, Rizzino A (2008) Small increases in the level of Sox2 trigger the differentiation of mouse embryonic stem cells. Stem Cells 26:903–911CrossRefGoogle Scholar
  22. Krawchuk D, Honma-Yamanaka N, Anani S, Yamanaka Y (2013) FGF4 is a limiting factor controlling the proportions of primitive endoderm and epiblast in the ICM of the mouse blastocyst. Dev Biol 384:65–71CrossRefGoogle Scholar
  23. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A (2007) FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 134:2895–2902CrossRefGoogle Scholar
  24. Kuo HP, Lee DF, Chen CT, Liu M, Chou CK, Lee HJ, Du Y, Xie X, Wei Y, Xia W, Weihua Z, Yang JY, Yen CJ, Huang TH, Tan M, Xing G, Zhao Y, Lin CH, Tsai SF, Fidler IJ, Hung MC (2010) ARD1 stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal 3:ra9CrossRefGoogle Scholar
  25. Lee CC, Peng SH, Shen L, Lee CF, Du TH, Kang ML, Xu GL, Upadhyay AK, Cheng X, Yan YT, Zhang Y, Juan LJ (2017) The role of N-alpha-acetyltransferase 10 protein in DNA methylation and genomic imprinting. Mol Cell 68:89–103 e107Google Scholar
  26. Lee MN, Kweon HY, Oh GT (2018) N-alpha-acetyltransferase 10 (NAA10) in development: the role of NAA10. Exp Mol Med 50:87Google Scholar
  27. Lim CY, Tam WL, Zhang J, Ang HS, Jia H, Lipovich L, Ng HH, Wei CL, Sung WK, Robson P, Yang H, Lim B (2008) Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell 3:543–554CrossRefGoogle Scholar
  28. Liszczak G, Goldberg JM, Foyn H, Petersson EJ, Arnesen T, Marmorstein R (2013) Molecular basis for N-terminal acetylation by the heterodimeric NatA complex. Nat Struct Mol Biol 20:1098–1105CrossRefGoogle Scholar
  29. Loh KM, Lim B (2011) A precarious balance: pluripotency factors as lineage specifiers. Cell Stem Cell 8:363–369CrossRefGoogle Scholar
  30. Loh KM, Lim B, Ang LT (2015) Ex uno plures: molecular designs for embryonic pluripotency. Physiol Rev 95:245–295CrossRefGoogle Scholar
  31. Lu R, Yang A, Jin Y (2011) Dual functions of T-box 3 (Tbx3) in the control of self-renewal and extraembryonic endoderm differentiation in mouse embryonic stem cells. J Biol Chem 286:8425–8436CrossRefGoogle Scholar
  32. Martinez Arias A, Brickman JM (2011) Gene expression heterogeneities in embryonic stem cell populations: origin and function. Curr Opin Cell Biol 23:650–656CrossRefGoogle Scholar
  33. Molotkov A, Mazot P, Brewer JR, Cinalli RM, Soriano P (2017) Distinct requirements for FGFR1 and FGFR2 in primitive endoderm development and exit from pluripotency. Dev Cell 41:511–526 e514Google Scholar
  34. Nichols J, Silva J, Roode M, Smith A (2009) Suppression of Erk signalling promotes ground state pluripotency in the mouse embryo. Development 136:3215–3222CrossRefGoogle Scholar
  35. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372–376CrossRefGoogle Scholar
  36. Ornitz DM, Itoh N (2015) The fibroblast growth factor signaling pathway. Wiley Interdiscip Rev Dev Biol 4:215–266CrossRefGoogle Scholar
  37. Pang AL, Peacock S, Johnson W, Bear DH, Rennert OM, Chan WY (2009) Cloning, characterization, and expression analysis of the novel acetyltransferase retrogene Ard1b in the mouse. Biol Reprod 81:302–309CrossRefGoogle Scholar
  38. Ree R, Varland S, Arnesen T (2018) Spotlight on protein N-terminal acetylation. Exp Mol Med 50:90CrossRefGoogle Scholar
  39. Rope AF, Wang K, Evjenth R, Xing J, Johnston JJ, Swensen JJ, Johnson WE, Moore B, Huff CD, Bird LM, Carey JC, Opitz JM, Stevens CA, Jiang T, Schank C, Fain HD, Robison R, Dalley B, Chin S, South ST, Pysher TJ, Jorde LB, Hakonarson H, Lillehaug JR, Biesecker LG, Yandell M, Arnesen T, Lyon GJ (2011) Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. Am J Hum Genet 89:28–43CrossRefGoogle Scholar
  40. Schroter C, Rue P, Mackenzie JP, Martinez Arias A (2015) FGF/MAPK signaling sets the switching threshold of a bistable circuit controlling cell fate decisions in embryonic stem cells. Development 142:4205–4216CrossRefGoogle Scholar
  41. Taleahmad S, Mirzaei M, Samadian A, Hassani SN, Haynes PA, Salekdeh GH, Baharvand H (2017) Low focal adhesion signaling promotes ground state pluripotency of mouse embryonic stem cells. J Proteome Res 16:3585–3595CrossRefGoogle Scholar
  42. Teo AK, Arnold SJ, Trotter MW, Brown S, Ang LT, Chng Z, Robertson EJ, Dunn NR, Vallier L (2011) Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev 25:238–250CrossRefGoogle Scholar
  43. Toya SP, Wary KK, Mittal M, Li F, Toth PT, Park C, Rehman J, Malik AB (2015) Integrin alpha6beta1 expressed in ESCs instructs the differentiation to endothelial cells. Stem Cells 33:1719–1729CrossRefGoogle Scholar
  44. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L (2012) Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc 7:562–578CrossRefGoogle Scholar
  45. Uda Y, Poh YC, Chowdhury F, Wu DC, Tanaka TS, Sato M, Wang N (2011) Force via integrins but not E-cadherin decreases Oct3/4 expression in embryonic stem cells. Biochem Biophys Res Commun 415:396–400CrossRefGoogle Scholar
  46. Uranishi K, Akagi T, Sun C, Koide H, Yokota T (2013) Dax1 associates with Esrrb and regulates its function in embryonic stem cells. Mol Cell Biol 33:2056–2066CrossRefGoogle Scholar
  47. Vallier L, Mendjan S, Brown S, Chng Z, Teo A, Smithers LE, Trotter MW, Cho CH, Martinez A, Rugg-Gunn P, Brons G, Pedersen RA (2009) Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136:1339–1349CrossRefGoogle Scholar
  48. Varshavsky A (2011) The N-end rule pathway and regulation by proteolysis. Protein Sci 20:1298–1345CrossRefGoogle Scholar
  49. Vitillo L, Kimber SJ (2017) Integrin and FAK regulation of human pluripotent stem cells. Curr Stem Cell Rep 3:358–365CrossRefGoogle Scholar
  50. Wang Z, Oron E, Nelson B, Razis S, Ivanova N (2012) Distinct lineage specification roles for NANOG, OCT4, and SOX2 in human embryonic stem cells. Cell Stem Cell 10:440–454CrossRefGoogle Scholar
  51. Weidgang CE, Seufferlein T, Kleger A, Mueller M (2016) Pluripotency factors on their lineage move. Stem Cells Int 2016:6838253CrossRefGoogle Scholar
  52. Weinberger L, Ayyash M, Novershtern N, Hanna JH (2016) Dynamic stem cell states: naive to primed pluripotency in rodents and humans. Nat Rev Mol Cell Biol 17:155–169CrossRefGoogle Scholar
  53. Wu Y, Lyon GJ (2018) NAA10-related syndrome. Exp Mol Med 50:85CrossRefGoogle Scholar
  54. Yamanaka Y, Lanner F, Rossant J (2010) FGF signal-dependent segregation of primitive endoderm and epiblast in the mouse blastocyst. Development 137:715–724CrossRefGoogle Scholar
  55. Yoon H, Kim HL, Chun YS, Shin DH, Lee KH, Shin CS, Lee DY, Kim HH, Lee ZH, Ryoo HM, Lee MN, Oh GT, Park JW (2014) NAA10 controls osteoblast differentiation and bone formation as a feedback regulator of Runx2. Nat Commun 5:5176CrossRefGoogle Scholar
  56. Yu P, Pan G, Yu J, Thomson JA (2011) FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation. Cell Stem Cell 8:326–334CrossRefGoogle Scholar
  57. Zeineddine D, Papadimou E, Chebli K, Gineste M, Liu J, Grey C, Thurig S, Behfar A, Wallace VA, Skerjanc IS, Puceat M (2006) Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development. Dev Cell 11:535–546CrossRefGoogle Scholar
  58. Zhang J, Tam WL, Tong GQ, Wu Q, Chan HY, Soh BS, Lou Y, Yang J, Ma Y, Chai L, Ng HH, Lufkin T, Robson P, Lim B (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 8:1114–1123CrossRefGoogle Scholar

Copyright information

© The Society for In Vitro Biology 2019

Authors and Affiliations

  1. 1.Department of Integrated Basic Medical Science, Division of Functional HistologyEhime University School of MedicineToonJapan

Personalised recommendations